Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2019

Open Access 01-12-2019 | Breast Cancer | Research

Reliability and validity of Amharic version of EORTC QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among breast cancer patients in Ethiopia

Authors: Diriba Alemayehu Gadisa, Esayas Tadesse Gebremariam, Getnet Yimer Ali

Published in: Health and Quality of Life Outcomes | Issue 1/2019

Login to get access

Abstract

Background

Breast cancer is the most common cancer among women and it affects quality of life of those women. So far, the two most frequently used tools for assessing health related quality of life in breast cancer patients, EORTC QLQ-C30 and EORTC QLQ-BR23 modules, were not validated in Ethiopia. Hence, the present study aimed to assess the psychometric properties of the tools among Ethiopian breast cancer patients.

Methods

Institutional based longitudinal study was conducted from January 1 to May 1, 2017 GC at only nationwide oncology center, Tikur Anbessa Specialized Hospital (TASH), Addis Ababa, Ethiopia. A total of 146 patients who visited the facility during that period, with no missing quality of life data, were selected for analysis. The psychometric properties of the EORTC QLQ-C30 and EORTC QLQ-BR23 were evaluated in terms of reliability, convergent, divergent, construct and clinical validity using SPSS version 22.

Results

Satisfactory internal consistency reliability (Cronbach’s α coefficients > 0.7) was confirmed, except for cognitive function (α = 0.516) of EORTC QLQ-C30 and body image (α = 0.510) of EORTC QLQ-BR23. Multiple-trait scaling analysis demonstrated a good convergent and divergent validity. No scaling errors were observed. Most items in EORTC QLQ-BR23 possessed a weak or no correlation with its own dimension in EORTC QLQ-C30 (r < 0.4) except with some of symptom scales. A statistically significant chemotherapy induced quality of life scores changes (P ≤ 0.05) were observed in all dimensions of both instruments between baseline and the end of first cycle chemotherapy, except for body image (P = 0.985) and sexual enjoyment (P = 0.817) of EORTC QLQ-BR23, indicating clinical validity.

Conclusion

Amharic version of the EORTC QLQ-C30 and EORTC QLQ-BR23 modules are valid and adequately reliable tool and can be used for clinical and epidemiological cancer researches to study the health related quality of life (HRQoL) of women with breast cancer in Ethiopia.
Literature
2.
go back to reference Osoba D. Health-related quality of life and cancer clinical trials. Ther Adv Med Oncol. 2011;3(2):57–71.CrossRef Osoba D. Health-related quality of life and cancer clinical trials. Ther Adv Med Oncol. 2011;3(2):57–71.CrossRef
3.
go back to reference Velikova G, Coens C, Efficace F, Greimel E, Groenvold M, Johnson C, et al. Health-related quality of life in EORTC clinical trials - 30 years of progress from methodological developments to making a real impact on oncology practice. Eur J Cancer. 2012;10(1):141–9.CrossRef Velikova G, Coens C, Efficace F, Greimel E, Groenvold M, Johnson C, et al. Health-related quality of life in EORTC clinical trials - 30 years of progress from methodological developments to making a real impact on oncology practice. Eur J Cancer. 2012;10(1):141–9.CrossRef
4.
go back to reference Silpakit C, Sirilerttrakul S, Jirajarus M, Thitiya Sirisinha ES, Ratanatharathorn V. The European Organization for Research and Treatment of Cancer quality of life questionnaire (EORTC QLQ-C30): validation study of the Thai version. Qual Life Res. 2006;15(1):167–72.CrossRef Silpakit C, Sirilerttrakul S, Jirajarus M, Thitiya Sirisinha ES, Ratanatharathorn V. The European Organization for Research and Treatment of Cancer quality of life questionnaire (EORTC QLQ-C30): validation study of the Thai version. Qual Life Res. 2006;15(1):167–72.CrossRef
5.
go back to reference Nejjari C, El Fakir S, Bendahhou K, El Rhazi K, Abda N, Zidouh A, et al. Translation and validation of European organization for research and treatment of cancer quality of life questionnaire -C30 into Moroccan version for cancer patients in Morocco. BMC Res Notes. 2014;7:228.CrossRef Nejjari C, El Fakir S, Bendahhou K, El Rhazi K, Abda N, Zidouh A, et al. Translation and validation of European organization for research and treatment of cancer quality of life questionnaire -C30 into Moroccan version for cancer patients in Morocco. BMC Res Notes. 2014;7:228.CrossRef
6.
go back to reference Niu H, Niu C, Wang J, Zhang Y, He P. Health-related quality of life in women with breast Cancer : a literature-based review of psychometric properties of breast cancer-specific measures. Asian Pac J Cancer Prev. 2014;15(8):3533–6.CrossRef Niu H, Niu C, Wang J, Zhang Y, He P. Health-related quality of life in women with breast Cancer : a literature-based review of psychometric properties of breast cancer-specific measures. Asian Pac J Cancer Prev. 2014;15(8):3533–6.CrossRef
7.
go back to reference Perry S, Kowalski TL, Chang C. Quality of life assessment in women with breast cancer : benefits , acceptability and utilization. Health Qual Life Outcomes. 2007;5:24.CrossRef Perry S, Kowalski TL, Chang C. Quality of life assessment in women with breast cancer : benefits , acceptability and utilization. Health Qual Life Outcomes. 2007;5:24.CrossRef
8.
go back to reference Aaronson NK, te Velde A, Hopwood P, Muller M, Franklin J, Arraras JI, et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996;14(10):2756–68.CrossRef Aaronson NK, te Velde A, Hopwood P, Muller M, Franklin J, Arraras JI, et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996;14(10):2756–68.CrossRef
9.
go back to reference Montazeri A, Harirchi I, Vahdani M, Khaleghi F, Jarvandi S, Ebrahimi M, et al. The EORTC breast cancer-specific quality of life questionnaire (EORTC QLQ-BR23): translation and validation study of the Iranian version. Qual Life Res. 2000;9:177–84.CrossRef Montazeri A, Harirchi I, Vahdani M, Khaleghi F, Jarvandi S, Ebrahimi M, et al. The EORTC breast cancer-specific quality of life questionnaire (EORTC QLQ-BR23): translation and validation study of the Iranian version. Qual Life Res. 2000;9:177–84.CrossRef
10.
go back to reference Awad MA, Denic S, El Taji H. Validation of the European Organization for Research and Treatment of Cancer quality of life questionnaires for Arabic-speaking populations. Annals NY Acad Sci. 2008;1138:146–54.CrossRef Awad MA, Denic S, El Taji H. Validation of the European Organization for Research and Treatment of Cancer quality of life questionnaires for Arabic-speaking populations. Annals NY Acad Sci. 2008;1138:146–54.CrossRef
11.
go back to reference Ayana BA, Negash S, Yusuf L, Tigeneh W. Reliability and validity of Amharic version of EORTC QLQ-C 30 questionnaire among gynecological Cancer patients in Ethiopia. PLoS One. 2016;11(6):1–10.CrossRef Ayana BA, Negash S, Yusuf L, Tigeneh W. Reliability and validity of Amharic version of EORTC QLQ-C 30 questionnaire among gynecological Cancer patients in Ethiopia. PLoS One. 2016;11(6):1–10.CrossRef
14.
go back to reference Scott NW, Fayers PM, Aaronson NK, De Graeff A, Groenvold M, Koller M, et al. EORTC QLQ-C30 reference values. Brussels: EORTC Quality of Life Group; 2008. Scott NW, Fayers PM, Aaronson NK, De Graeff A, Groenvold M, Koller M, et al. EORTC QLQ-C30 reference values. Brussels: EORTC Quality of Life Group; 2008.
15.
go back to reference Fayers P, Aaronson N, Bjordal K, Groenvold M, Curran D, Bottomley A, et al. EORTC QLQ-C30 scoring manual. 3rd ed. Brussels: EORTC; 2001. Fayers P, Aaronson N, Bjordal K, Groenvold M, Curran D, Bottomley A, et al. EORTC QLQ-C30 scoring manual. 3rd ed. Brussels: EORTC; 2001.
16.
go back to reference Sharp LK, Knight SJ, Nadler R, Albers M, Moran E, Kuzel T, et al. Quality of life in low-income patients with metastatic prostate Cancer : divergent and convergent validity of three instruments. Qual Life Res. 1999;8(5):461–70.CrossRef Sharp LK, Knight SJ, Nadler R, Albers M, Moran E, Kuzel T, et al. Quality of life in low-income patients with metastatic prostate Cancer : divergent and convergent validity of three instruments. Qual Life Res. 1999;8(5):461–70.CrossRef
17.
go back to reference Cerezo O, Oñate-Ocaña LF, Arrieta-Joffe P, González-Lara F, García-Pasquel MJ, Bargalló-Rocha E, et al. Validation of the Mexican-Spanish version of the EORTC QLQ-C30 and BR23 questionnaires to assess health-related quality of life in Mexican women with breast cancer. Eur J Cancer Care. 2012;21(5):684–91.CrossRef Cerezo O, Oñate-Ocaña LF, Arrieta-Joffe P, González-Lara F, García-Pasquel MJ, Bargalló-Rocha E, et al. Validation of the Mexican-Spanish version of the EORTC QLQ-C30 and BR23 questionnaires to assess health-related quality of life in Mexican women with breast cancer. Eur J Cancer Care. 2012;21(5):684–91.CrossRef
18.
go back to reference Shuleta-Qehaja S, Sterjev Z, Shuturkova L. Valuation of reliability and validity of the european organization for research and treatment of cancer quality of life questionnaire (EORTC QLQ-C30, Albanian version) among breast cancer patients from Kosovo. Patient Prefer Adherence. 2015;9:459–65.CrossRef Shuleta-Qehaja S, Sterjev Z, Shuturkova L. Valuation of reliability and validity of the european organization for research and treatment of cancer quality of life questionnaire (EORTC QLQ-C30, Albanian version) among breast cancer patients from Kosovo. Patient Prefer Adherence. 2015;9:459–65.CrossRef
20.
go back to reference Luo N, Fones CSL, Lim SE, Xie F, Thumboo J, Li SC. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire ( EORTC QLQ-C30 ): Validation of English version in Singapore. Qual Life Res. 2005;14:1181–6.CrossRef Luo N, Fones CSL, Lim SE, Xie F, Thumboo J, Li SC. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire ( EORTC QLQ-C30 ): Validation of English version in Singapore. Qual Life Res. 2005;14:1181–6.CrossRef
21.
go back to reference Sprangers BM, Groenvold M, Arraras JI, Franklin J, Velde A, Muller M, et al. The European Organization for Research and Treatment of Cancer breast Cancer-specific quality-of-life questionnaire module : first results from a three-country field study. J Clin Oncol. 1996;14(10):2756–68.CrossRef Sprangers BM, Groenvold M, Arraras JI, Franklin J, Velde A, Muller M, et al. The European Organization for Research and Treatment of Cancer breast Cancer-specific quality-of-life questionnaire module : first results from a three-country field study. J Clin Oncol. 1996;14(10):2756–68.CrossRef
22.
go back to reference Michels FAS, Latorre Mdo R, Maciel Mdo S. Validity , reliability and understanding of the EORTC-C30 and EORTC-BR23 , quality of life questionnaires specific for breast cancer. Rev Bras Epidemiol. 2013;16(2):352–63.CrossRef Michels FAS, Latorre Mdo R, Maciel Mdo S. Validity , reliability and understanding of the EORTC-C30 and EORTC-BR23 , quality of life questionnaires specific for breast cancer. Rev Bras Epidemiol. 2013;16(2):352–63.CrossRef
23.
go back to reference Tan ML, Idris DB, Teo LW, Loh SY, Seow GC. Validation of EORTC QLQ-C30 and QLQ-BR23 questionnaires in the measurement of quality of life of breast cancer patients in Singapore. Asia Pac J Oncol Nurs. 2014;1(1):22–32.CrossRef Tan ML, Idris DB, Teo LW, Loh SY, Seow GC. Validation of EORTC QLQ-C30 and QLQ-BR23 questionnaires in the measurement of quality of life of breast cancer patients in Singapore. Asia Pac J Oncol Nurs. 2014;1(1):22–32.CrossRef
Metadata
Title
Reliability and validity of Amharic version of EORTC QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among breast cancer patients in Ethiopia
Authors
Diriba Alemayehu Gadisa
Esayas Tadesse Gebremariam
Getnet Yimer Ali
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2019
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-019-1257-z

Other articles of this Issue 1/2019

Health and Quality of Life Outcomes 1/2019 Go to the issue